The blood culture tests market size has grown rapidly in recent years. It will grow from $7.51 billion in 2025 to $8.6 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to rising incidence of bloodstream infections, expansion of hospital laboratory infrastructure, increased adoption of culture-based diagnostics, growing antimicrobial resistance concerns, availability of automated laboratory instruments.
The blood culture tests market size is expected to see rapid growth in the next few years. It will grow to $14.77 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic results, rising adoption of AI-assisted laboratory workflows, expansion of molecular testing capabilities, growing focus on infection control programs, technological advancements in blood culture analytics. Major trends in the forecast period include increasing adoption of automated blood culture systems, rising use of molecular diagnostic technologies, growing integration of rapid pathogen identification tools, expansion of continuous monitoring blood culture platforms, enhanced focus on early sepsis detection.
The rising incidence of infectious diseases is expected to drive the growth of the blood culture test market. Infectious diseases are caused by pathogens such as viruses, bacteria, fungi, and parasites. These harmful microorganisms can enter the body from external sources or through contact with an infected individual. Diseases like COVID-19, tuberculosis, the flu, measles, HIV, and strep throat can cause temporary discomfort, severe tissue damage, or even death. The World Health Organization identifies infectious diseases as the second leading cause of death globally. This increase in infectious disease cases has fueled the demand for blood culture tests, which help determine whether a patient has bacteremia or septicemia, potentially life-threatening conditions. For example, in August 2024, according to a report by the UK Health Security Agency, as of December 31, 2022, there were 3,732 confirmed mpox cases in the UK, primarily in England. By May 31, 2023, 21 additional cases were reported, mainly in England, with one in Scotland. As a result, the growing incidence of infectious diseases is driving demand for blood culture tests.
Major companies in the organic blood culture tests market are focusing on developing advanced technologies, such as clinical chemistry technologies, to improve diagnostic accuracy, decrease turnaround times, and enhance patient management through integrated testing solutions that deliver comprehensive insights into infections and related health issues. Clinical chemistry technologies refer to diagnostic methods and instruments utilized to analyze bodily fluids, primarily blood, to measure chemical components and evaluate health conditions. For example, in April 2024, Mindray Medical International Limited, a medical device company based in China, launched mid-volume laboratories. These innovations demonstrate Mindray's dedication to supporting mid-volume laboratories by offering simple yet effective solutions that boost diagnostic capabilities while meeting the growing demands of healthcare providers.
In February 2024, Bruker Corporation acquired ELITechGroup for USD 1.0 billion (€870 million) to strengthen its blood culture testing capabilities. The acquisition allows Bruker to integrate ELITechGroup’s molecular diagnostic assays for blood-borne pathogens and expand its portfolio of automated microbiology systems and consumables. ELITechGroup’s sample-to-answer platforms, PCR assays, and automated instruments enhance Bruker’s offerings in clinical diagnostics, supporting faster, more accurate infectious disease testing. This strategic move reflects the growing trend in life-science diagnostics toward consolidation and portfolio expansion to provide comprehensive, automated solutions for laboratories and clinical settings.
Major companies operating in the blood culture tests market are Becton Dickinson and Company, BioMerieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Danaher Corporation, F. Hoffmann-La Roche AG, Biobase Biotech Co. Ltd., Scenker Biological Technology Co. Ltd., Anaerobe Systems Inc., Himedia Laboratories Pvt. Ltd., Autobio Diagnostics Co. Ltd., Roche Diagnostics, Mikroscan Technologies Inc., Hardy Diagnostics, Siemens Healthineers, Abbott Laboratories, Cepheid, T2 Biosystems Inc., Beckman Coulter Inc., Accelerate Diagnostics, Bio-Rad Laboratories Inc., Copan Diagnostics Inc., Greiner Bio-One International GmbH, GenMark Diagnostics, Meridian Bioscience Inc.
North America was the largest region in the blood culture tests market in 2025. The regions covered in the blood culture tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood culture tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the blood culture tests market by increasing costs of imported reagents, culture bottles, automated instruments, sensors, and laboratory electronics. Hospital and reference laboratories in North America and Europe are most affected due to reliance on imported diagnostic systems, while Asia-Pacific faces higher costs for manufacturing and exporting consumables. These tariffs are increasing testing costs and extending equipment replacement cycles. However, they are also encouraging domestic reagent production, local instrument assembly, and regional laboratory supply chain development.
The blood culture tests market research report is one of a series of new reports that provides blood culture tests market statistics, including blood culture tests industry global market size, regional shares, competitors with a blood culture tests market share, detailed blood culture tests market segments, market trends and opportunities, and any further data you may need to thrive in the blood culture tests industry. This blood culture tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood culture tests are diagnostic procedures designed to identify disease-causing microorganisms present in the bloodstream. These tests play a crucial role in detecting infections caused by various microorganisms such as bacteria, yeast, and other foreign invaders in a blood sample.
The primary methods employed in blood culture tests include conventional/manual methods and automated methods. The conventional or manual method is utilized to detect invaders like bacteria, yeast, and other microorganisms in a blood specimen. Manual testing involves the hands-on examination and interpretation of results by skilled testers. Blood culture products encompass consumables, instruments, and software and services that leverage technologies such as culture-based technology, molecular technologies, microarrays, PCR (polymerase chain reaction), PNA-FISH (peptide nucleic acid - fluorescent in situ hybridization), and proteomics technology. These technologies are applied in the detection of bacteremia, fungemia, and mycobacterial infections. Blood culture tests are commonly utilized by hospital laboratories, reference laboratories, academic research laboratories, and other testing facilities.
The blood culture tests include revenues earned by entities by micro sampling technology and blood chemistry analyzer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood culture tests market size is expected to see rapid growth in the next few years. It will grow to $14.77 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic results, rising adoption of AI-assisted laboratory workflows, expansion of molecular testing capabilities, growing focus on infection control programs, technological advancements in blood culture analytics. Major trends in the forecast period include increasing adoption of automated blood culture systems, rising use of molecular diagnostic technologies, growing integration of rapid pathogen identification tools, expansion of continuous monitoring blood culture platforms, enhanced focus on early sepsis detection.
The rising incidence of infectious diseases is expected to drive the growth of the blood culture test market. Infectious diseases are caused by pathogens such as viruses, bacteria, fungi, and parasites. These harmful microorganisms can enter the body from external sources or through contact with an infected individual. Diseases like COVID-19, tuberculosis, the flu, measles, HIV, and strep throat can cause temporary discomfort, severe tissue damage, or even death. The World Health Organization identifies infectious diseases as the second leading cause of death globally. This increase in infectious disease cases has fueled the demand for blood culture tests, which help determine whether a patient has bacteremia or septicemia, potentially life-threatening conditions. For example, in August 2024, according to a report by the UK Health Security Agency, as of December 31, 2022, there were 3,732 confirmed mpox cases in the UK, primarily in England. By May 31, 2023, 21 additional cases were reported, mainly in England, with one in Scotland. As a result, the growing incidence of infectious diseases is driving demand for blood culture tests.
Major companies in the organic blood culture tests market are focusing on developing advanced technologies, such as clinical chemistry technologies, to improve diagnostic accuracy, decrease turnaround times, and enhance patient management through integrated testing solutions that deliver comprehensive insights into infections and related health issues. Clinical chemistry technologies refer to diagnostic methods and instruments utilized to analyze bodily fluids, primarily blood, to measure chemical components and evaluate health conditions. For example, in April 2024, Mindray Medical International Limited, a medical device company based in China, launched mid-volume laboratories. These innovations demonstrate Mindray's dedication to supporting mid-volume laboratories by offering simple yet effective solutions that boost diagnostic capabilities while meeting the growing demands of healthcare providers.
In February 2024, Bruker Corporation acquired ELITechGroup for USD 1.0 billion (€870 million) to strengthen its blood culture testing capabilities. The acquisition allows Bruker to integrate ELITechGroup’s molecular diagnostic assays for blood-borne pathogens and expand its portfolio of automated microbiology systems and consumables. ELITechGroup’s sample-to-answer platforms, PCR assays, and automated instruments enhance Bruker’s offerings in clinical diagnostics, supporting faster, more accurate infectious disease testing. This strategic move reflects the growing trend in life-science diagnostics toward consolidation and portfolio expansion to provide comprehensive, automated solutions for laboratories and clinical settings.
Major companies operating in the blood culture tests market are Becton Dickinson and Company, BioMerieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Danaher Corporation, F. Hoffmann-La Roche AG, Biobase Biotech Co. Ltd., Scenker Biological Technology Co. Ltd., Anaerobe Systems Inc., Himedia Laboratories Pvt. Ltd., Autobio Diagnostics Co. Ltd., Roche Diagnostics, Mikroscan Technologies Inc., Hardy Diagnostics, Siemens Healthineers, Abbott Laboratories, Cepheid, T2 Biosystems Inc., Beckman Coulter Inc., Accelerate Diagnostics, Bio-Rad Laboratories Inc., Copan Diagnostics Inc., Greiner Bio-One International GmbH, GenMark Diagnostics, Meridian Bioscience Inc.
North America was the largest region in the blood culture tests market in 2025. The regions covered in the blood culture tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood culture tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the blood culture tests market by increasing costs of imported reagents, culture bottles, automated instruments, sensors, and laboratory electronics. Hospital and reference laboratories in North America and Europe are most affected due to reliance on imported diagnostic systems, while Asia-Pacific faces higher costs for manufacturing and exporting consumables. These tariffs are increasing testing costs and extending equipment replacement cycles. However, they are also encouraging domestic reagent production, local instrument assembly, and regional laboratory supply chain development.
The blood culture tests market research report is one of a series of new reports that provides blood culture tests market statistics, including blood culture tests industry global market size, regional shares, competitors with a blood culture tests market share, detailed blood culture tests market segments, market trends and opportunities, and any further data you may need to thrive in the blood culture tests industry. This blood culture tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood culture tests are diagnostic procedures designed to identify disease-causing microorganisms present in the bloodstream. These tests play a crucial role in detecting infections caused by various microorganisms such as bacteria, yeast, and other foreign invaders in a blood sample.
The primary methods employed in blood culture tests include conventional/manual methods and automated methods. The conventional or manual method is utilized to detect invaders like bacteria, yeast, and other microorganisms in a blood specimen. Manual testing involves the hands-on examination and interpretation of results by skilled testers. Blood culture products encompass consumables, instruments, and software and services that leverage technologies such as culture-based technology, molecular technologies, microarrays, PCR (polymerase chain reaction), PNA-FISH (peptide nucleic acid - fluorescent in situ hybridization), and proteomics technology. These technologies are applied in the detection of bacteremia, fungemia, and mycobacterial infections. Blood culture tests are commonly utilized by hospital laboratories, reference laboratories, academic research laboratories, and other testing facilities.
The blood culture tests include revenues earned by entities by micro sampling technology and blood chemistry analyzer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Culture Tests Market Characteristics
3. Blood Culture Tests Market Supply Chain Analysis
4. Global Blood Culture Tests Market Trends and Strategies
5. Blood Culture Tests Market Analysis of End Use Industries
7. Global Blood Culture Tests Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Culture Tests Total Addressable Market (TAM) Analysis for the Market
9. Blood Culture Tests Market Segmentation
10. Blood Culture Tests Market Regional and Country Analysis
11. Asia-Pacific Blood Culture Tests Market
12. China Blood Culture Tests Market
13. India Blood Culture Tests Market
14. Japan Blood Culture Tests Market
15. Australia Blood Culture Tests Market
16. Indonesia Blood Culture Tests Market
17. South Korea Blood Culture Tests Market
18. Taiwan Blood Culture Tests Market
19. South East Asia Blood Culture Tests Market
20. Western Europe Blood Culture Tests Market
21. UK Blood Culture Tests Market
22. Germany Blood Culture Tests Market
23. France Blood Culture Tests Market
24. Italy Blood Culture Tests Market
25. Spain Blood Culture Tests Market
26. Eastern Europe Blood Culture Tests Market
27. Russia Blood Culture Tests Market
28. North America Blood Culture Tests Market
29. USA Blood Culture Tests Market
30. Canada Blood Culture Tests Market
31. South America Blood Culture Tests Market
32. Brazil Blood Culture Tests Market
33. Middle East Blood Culture Tests Market
34. Africa Blood Culture Tests Market
36. Blood Culture Tests Market Competitive Landscape and Company Profiles
37. Blood Culture Tests Market Other Major and Innovative Companies
40. Blood Culture Tests Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Blood Culture Tests Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood culture tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood culture tests? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood culture tests market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Method: Conventional/Manual Methods; Automated Methods2) By Product: Consumables; Instruments; Software and Services
3) By Technology: Culture-Based Technology; Molecular Technologies; Microarrays; PCR (Polymerase Chain Reaction); PNA-FiSH (Peptide Nucleic Acid - Fluorescent in Situ Hybridization); Proteomics Technology
4) By Application: Bacteremia; Fungemia; Mycobacterial Detection
5) By End User: Hospital Laboratories; Reference Laboratories; Academic Research Laboratories; Other Laboratories
Subsegments:
1) By Conventional/Manual Methods: Blood Culture Bottles (Aerobic and Anaerobic); Culture Media Preparation; Manual Observation and Identification2) By Automated Methods: Automated Blood Culture Systems; Continuous Monitoring Systems; Integrated Identification and Sensitivity Testing Systems
Companies Mentioned: Becton Dickinson and Company; BioMerieux SA; Thermo Fisher Scientific Inc.; Luminex Corporation; Danaher Corporation; F. Hoffmann-La Roche AG; Biobase Biotech Co. Ltd.; Scenker Biological Technology Co. Ltd.; Anaerobe Systems Inc.; Himedia Laboratories Pvt. Ltd.; Autobio Diagnostics Co. Ltd.; Roche Diagnostics; Mikroscan Technologies Inc.; Hardy Diagnostics; Siemens Healthineers; Abbott Laboratories; Cepheid; T2 Biosystems Inc.; Beckman Coulter Inc.; Accelerate Diagnostics; Bio-Rad Laboratories Inc.; Copan Diagnostics Inc.; Greiner Bio-One International GmbH; GenMark Diagnostics; Meridian Bioscience Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Culture Tests market report include:- Becton Dickinson and Company
- BioMerieux SA
- Thermo Fisher Scientific Inc.
- Luminex Corporation
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Biobase Biotech Co. Ltd.
- Scenker Biological Technology Co. Ltd.
- Anaerobe Systems Inc.
- Himedia Laboratories Pvt. Ltd.
- Autobio Diagnostics Co. Ltd.
- Roche Diagnostics
- Mikroscan Technologies Inc.
- Hardy Diagnostics
- Siemens Healthineers
- Abbott Laboratories
- Cepheid
- T2 Biosystems Inc.
- Beckman Coulter Inc.
- Accelerate Diagnostics
- Bio-Rad Laboratories Inc.
- Copan Diagnostics Inc.
- Greiner Bio-One International GmbH
- GenMark Diagnostics
- Meridian Bioscience Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.6 Billion |
| Forecasted Market Value ( USD | $ 14.77 Billion |
| Compound Annual Growth Rate | 14.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
